Head and Neck Cancer Trial, Recruiting NCT07242859 Sponsor: Christina Milad Lobos Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07242859
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People diagnosed with squamous cell carcinoma (a type of cancer) in the head and neck area, where the cancer has not spread from another part of the body
  • People who are well enough to undergo radiotherapy, as measured by a standard health scale (ECOG score of 0, 1, or 2)
  • People who will receive a specific type of radiation treatment called IMRT, either as a main treatment or after surgery, with or without chemotherapy given at the same time
  • People who are willing and able to sign a written consent form

Who may not be able to join:

  • People currently receiving any cancer treatment other than those specifically allowed in this trial
  • People who are pregnant or breastfeeding
  • People who have mouth sores or other oral conditions that are not related to their cancer or its treatment
  • People taking medications that can cause mouth sores, or people taking blood-thinning medications (anticoagulants)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +20 1005279101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Christina Milad Lobos
Registry
ClinicalTrials.gov
Start date
15 January 2023
Est. completion
30 November 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Incidence of grade ≥ 3 mucositis .

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov